ImmunIGY Consortium Named Finalist for Groundbreaking Calf Colostrum Test

We are thrilled to announce that the ImmunIGY consortium, including SOMA Bioscience, Synergy Farm Health and Buitelaar Group and sales distributor partner Bimeda Animal Health, has been named a finalist for the groundbreaking ImmunIGY test! Developed at our Long Lane Development Farm, ImmunIGY represents a major leap forward in calf health and sustainability.

Leading Innovation at Long Lane Development Farm

Developed at Buitelaar’s Long Lane Development Farm, the ImmunIGY test is the first of its kind. This innovative lateral flow test measures the amount of immunoglobulin (antibody) a calf has received through colostrum intake, a critical factor in the calf's health and immunity. For the first time, this test can be administered upon calf entry to the rearing unit, providing valuable insights and benefits across the supply chain.

Investing in the Future of Farming

The ImmunIGY consortium’s investment in research and development is a testament to our collective commitment to advancing the livestock industry. The ImmunIGY test is a clear example of how we are pushing the boundaries of what's possible, improving health, productivity, and sustainability across the sector.

A Collaborative Effort

The development of the ImmunIGY test is a collaborative success, made possible by the strong partnerships within the consortium, with Bimeda Animal Health holding the global sales and distribution rights. Together, we are setting new standards in calf health management and working towards a more sustainable future.

Learn More

For more information about ImmunIGY and how it’s transforming livestock health management, visit the ImmunIGY website: https://calf-immunity.co.uk/.